1. Home
  2. CERO vs STRR Comparison

CERO vs STRR Comparison

Compare CERO & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • STRR
  • Stock Information
  • Founded
  • CERO 2017
  • STRR 1985
  • Country
  • CERO United States
  • STRR United States
  • Employees
  • CERO N/A
  • STRR N/A
  • Industry
  • CERO
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CERO
  • STRR Health Care
  • Exchange
  • CERO Nasdaq
  • STRR Nasdaq
  • Market Cap
  • CERO 8.4M
  • STRR 7.0M
  • IPO Year
  • CERO N/A
  • STRR N/A
  • Fundamental
  • Price
  • CERO $2.04
  • STRR $2.10
  • Analyst Decision
  • CERO
  • STRR
  • Analyst Count
  • CERO 0
  • STRR 0
  • Target Price
  • CERO N/A
  • STRR N/A
  • AVG Volume (30 Days)
  • CERO 1.3M
  • STRR 11.0K
  • Earning Date
  • CERO 02-20-2025
  • STRR 03-21-2025
  • Dividend Yield
  • CERO N/A
  • STRR N/A
  • EPS Growth
  • CERO N/A
  • STRR N/A
  • EPS
  • CERO N/A
  • STRR N/A
  • Revenue
  • CERO N/A
  • STRR $50,375,000.00
  • Revenue This Year
  • CERO N/A
  • STRR $15.58
  • Revenue Next Year
  • CERO N/A
  • STRR $36.27
  • P/E Ratio
  • CERO N/A
  • STRR N/A
  • Revenue Growth
  • CERO N/A
  • STRR 2.22
  • 52 Week Low
  • CERO $1.76
  • STRR $2.06
  • 52 Week High
  • CERO $1,238.00
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • CERO 32.64
  • STRR 37.94
  • Support Level
  • CERO $1.76
  • STRR $2.13
  • Resistance Level
  • CERO $3.18
  • STRR $2.24
  • Average True Range (ATR)
  • CERO 0.35
  • STRR 0.08
  • MACD
  • CERO 0.28
  • STRR 0.01
  • Stochastic Oscillator
  • CERO 4.72
  • STRR 3.23

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: